Status | Study |
RECRUITING |
Study Name: Carpal Tunnel Release With Risk Factors for Amyloidosis Condition: Amyloidosis Date: 2023-03-16 Interventions: Carpal tunnel release surgery used to take a biopsy to diagnose amyloidosis and determine whether or not carpal tunnel syndrome can predict who's |
RECRUITING |
Study Name: Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis Condition: Amyloidosis Date: 2023-01-25 Interventions: Amyloid reactive protein used as imaging agent to detect systemic amyloidosis |
RECRUITING |
Study Name: Dietary Reporting In The Amyloidoses Condition: Amyloidosis Date: 2023-01-20 Interventions: Amyloidosis patients will use MyFitnessPal application to track dietary intake and use of herbal/alternative supplements in from week 2-9.P |
Not yet recruiting |
Study Name: Study in Subjects With Light Chain (AL) Amyloidosis Condition: AL Amyloidosis Date: 2017-04-28 Interventions: Drug: NEOD001 humanized monoclonal antibody |
Not yet recruiting |
Study Name: Renal AL Amyloid Involvement and NEOD001 Condition: Amyloidosis Date: 2017-04-26 Interventions: Drug: NEOD001 NEOD001 is a mon |
Not yet recruiting |
Study Name: Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis Condition: Amyloidosis Immunoglobulin Light Chain Deposition Date: 2017-04-21 Interventions: Drug: Bortezomib Given SC |
Enrolling by invitation |
Study Name: Return of Amyloid Imaging Results (Result Study) Condition: Mild Cognitive Impairment Date: 2017-04-14 Interventions: Other: Scan Opportunity Participants in the scan group are provided the option of having an amyloid PET |
Recruiting |
Study Name: PET/MRI Evaluation of Cardiac Amyloid Condition: Cardiac Amyloidosis Date: 2017-04-13 Interventions: Diagnostic Test: 18F‑Florbetaben (Neuraceq®) PET/MRI Administration of 8.0 mCi 18F‑Flor |
Not yet recruiting |
Study Name: A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease Condition: Alzheimer's Disease Date: 2017-04-05 Interventions: Drug: CNP520 50mg Arm#1 |
Not yet recruiting |
Study Name: Radioisotope Scintigraphy to Establish Incidence of Cardiac Amyloidosis Among Patients With Otherwise Unexplained Cardiac Disease Condition: Cardiac TTR Amyloidosis Date: 2017-03-28 Interventions: Diagnostic Test: Tc99m-labeled pyrophosphate scan Intravenous injection of Tc99m-labeled pyrophosphate w |